• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脱发治疗患者报告结局测量工具的研制与验证:HAIR-Q。

Development and validation of a patient-reported outcome measure for hair loss treatment: The HAIR-Q.

机构信息

Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada.

Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.

出版信息

J Cosmet Dermatol. 2024 Nov;23(11):3705-3715. doi: 10.1111/jocd.16465. Epub 2024 Jul 16.

DOI:10.1111/jocd.16465
PMID:39013033
Abstract

BACKGROUND

Patient-reported outcome measures (PROMs) for hair loss focus mainly on Alopecia Areata. We created a PROM (i.e., HAIR-Q) that is applicable to any hair loss condition. The HAIR-Q measures satisfaction with hair.

PATIENTS/METHODS: Concept elicitation interviews were conducted and analyzed to develop a draft scale. Content validity was established through multiple rounds of patient and expert input. Psychometric properties of the scale were examined in an online sample (i.e., Prolific) using Rasch measurement theory (RMT) analysis. Test-retest reliability and tests of construct validation were examined.

RESULTS

Content validity of a 22-item draft scale was established with input from 11 patients, 12 experts and an online Prolific sample of 59 people who had a variety of hair loss treatments. In the RMT analysis (n = 390), 8 items were dropped. Data for the 14-item scale fit the Rasch model (χ = 89.85, df = 70, p = 0.06). All 14 items had ordered thresholds and good item fit. Reliability was high with person separation index and Cronbach alpha values ≥0.91, and intraclass correlation coefficient of 0.94 based on a sample of 97 participants. Higher (better) scores on the scale were associated with having more hair, looking younger than ones' age, satisfaction with hair overall, being less bothered by hair loss, and for those who had a hair loss treatment in the past year, being more satisfied with their hair now than before treatment (p < 0.001).

CONCLUSION

The HAIR-Q evidenced reliability and validity and can be used in research and to inform clinical care to measure satisfaction with hair from the patient perspective.

摘要

背景

针对脱发的患者报告结局测量(PROMs)主要集中在斑秃上。我们创建了一个适用于任何脱发状况的 PROM(即 HAIR-Q)。HAIR-Q 测量对头发的满意度。

患者/方法:通过概念启发访谈进行分析,以开发出一份草案量表。通过多次患者和专家的输入来确定内容的有效性。使用 Rasch 测量理论(RMT)分析在在线样本(即 Prolific)中检查量表的心理测量特性。检查了重测信度和结构验证测试。

结果

通过 11 名患者、12 名专家和 59 名在线 Prolific 样本的输入,确定了一个 22 项草案量表的内容有效性,这些人接受了各种脱发治疗。在 RMT 分析(n=390)中,有 8 项被删除。14 项量表的数据符合 Rasch 模型(χ=89.85,df=70,p=0.06)。所有 14 项都有有序的阈值和良好的项目拟合。信度高,个体分离指数和 Cronbach α 值均≥0.91,97 名参与者样本的组内相关系数为 0.94。量表上的得分越高(越好),表示头发越多、看起来比实际年龄年轻、对整体头发的满意度越高、对脱发的困扰越少,对于过去一年接受过脱发治疗的人,现在对头发的满意度比治疗前更高(p<0.001)。

结论

HAIR-Q 具有可靠性和有效性,可以用于研究和为临床护理提供信息,从患者的角度测量对头发的满意度。

相似文献

1
Development and validation of a patient-reported outcome measure for hair loss treatment: The HAIR-Q.脱发治疗患者报告结局测量工具的研制与验证:HAIR-Q。
J Cosmet Dermatol. 2024 Nov;23(11):3705-3715. doi: 10.1111/jocd.16465. Epub 2024 Jul 16.
2
Psychometric validation of the FACE-Q Aesthetics Satisfaction with Temples scale in individuals seeking minimally invasive treatment to improve temple hollowing.针对寻求微创治疗改善颞部凹陷人群的面部美学量表(FACE-Q)颞部美学满意度的心理测量学验证。
J Cosmet Dermatol. 2024 Nov;23(11):3517-3524. doi: 10.1111/jocd.16450. Epub 2024 Aug 5.
3
"I Want It to Look Natural": Development and Validation of the FACE-Q Aesthetics Natural Module.“我希望它看起来自然”:FACE-Q 美学自然模块的开发和验证。
Aesthet Surg J. 2024 Jun 14;44(7):733-743. doi: 10.1093/asj/sjad374.
4
Leveraging patient-reported outcomes data to inform oncology clinical decision making: Introducing the FACE-Q Head and Neck Cancer Module.利用患者报告结局数据为肿瘤学临床决策提供信息:引入 FACE-Q 头颈部癌症模块。
Cancer. 2019 Mar 15;125(6):863-872. doi: 10.1002/cncr.31900. Epub 2018 Nov 30.
5
Development and Psychometric Evaluation of the FACE-Q Scales for Patients Undergoing Rhinoplasty.隆鼻手术患者面部量表(FACE-Q)的开发与心理测量评估
JAMA Facial Plast Surg. 2016 Jan-Feb;18(1):27-35. doi: 10.1001/jamafacial.2015.1445.
6
Development and Validation of a Patient-Reported Outcome Measure for Fingernail and Toenail Conditions: The NAIL-Q.一种用于指甲疾病的患者报告结局量表的开发与验证:NAIL-Q量表
Clin Cosmet Investig Dermatol. 2023 Oct 27;16:3091-3105. doi: 10.2147/CCID.S429120. eCollection 2023.
7
The BODY-Q Stretch Marks Scale: A Development and Validation Study.身体质量指数妊娠纹量表:一项开发与验证研究。
Aesthet Surg J. 2018 Aug 16;38(9):990-997. doi: 10.1093/asj/sjy081.
8
Development and Validation of New BODY-Q Scales Measuring Expectations, Eating Behavior, Distress, Symptoms, and Work Life in 4004 Adults From 4 Countries.新的 BODY-Q 量表的制定与验证:4 个国家 4004 名成年人的期望、饮食行为、苦恼、症状和工作生活的测量。
Obes Surg. 2021 Aug;31(8):3637-3645. doi: 10.1007/s11695-021-05462-2. Epub 2021 May 27.
9
Development and Psychometric Validation of the FACE-Q Skin, Lips, and Facial Rhytids Appearance Scales and Adverse Effects Checklists for Cosmetic Procedures.用于美容手术的FACE-Q皮肤、嘴唇和面部皱纹外观量表及不良反应检查表的开发与心理测量学验证
JAMA Dermatol. 2016 Apr;152(4):443-51. doi: 10.1001/jamadermatol.2016.0018.
10
Development and Psychometric Validation of a Patient-Reported Outcome Measure for Arm Lymphedema: The LYMPH-Q Upper Extremity Module.手臂淋巴水肿患者报告结局量表的开发与心理测量学验证:LYMPH-Q上肢模块
Ann Surg Oncol. 2021 Sep;28(9):5166-5182. doi: 10.1245/s10434-021-09887-y. Epub 2021 Jul 5.

引用本文的文献

1
Advancing Hair Regrowth Assessment: Development and Standardization of Methods for Evaluating New Hair Growth, Hair Keratin Levels, and Scalp Health in Androgenetic Alopecia Patients.推进毛发再生评估:雄激素性脱发患者新发生长、毛发角蛋白水平及头皮健康评估方法的开发与标准化
Cureus. 2025 Feb 28;17(2):e79859. doi: 10.7759/cureus.79859. eCollection 2025 Feb.
2
Effectiveness of Combined Oral Minoxidil and Finasteride in Male Androgenetic Alopecia: A Retrospective Service Evaluation.口服米诺地尔与非那雄胺联合治疗男性雄激素性脱发的有效性:一项回顾性服务评估
Cureus. 2025 Jan 16;17(1):e77549. doi: 10.7759/cureus.77549. eCollection 2025 Jan.